GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Forte Biosciences Inc.
Forte Biosciences is a biotech company focused on treating inflammatory skin diseases. Its stock price follows a classic industry pattern, where the trajectory is determined not by current revenue, but by clinical trial results and hopes for new drug approvals.
Share prices of companies in the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company developing treatments for inflammatory skin diseases. We classify it in the "Pharmaceuticals (Skin Diseases)" segment, which seeks new solutions to improve patients' quality of life. The chart below shows how investors value this specialized sector.
Broad Market Index - GURU.Markets
Forte Biosciences is a biopharmaceutical company developing drugs for the treatment of inflammatory skin diseases. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the market, reflecting investor expectations for clinical trials.
Change in the price of a company, segment, and market as a whole per day
FBRX - Daily change in the company's share price Forte Biosciences Inc.
Forte Biosciences' daily volatility is measured by change_co. It reflects sensitivity to clinical trial results, which is typical for early-stage biotech companies. This metric is important for analyzing high-risk biotech assets on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma skin
Forte Biosciences, Inc. is a biotech company. This chart highlights the sector's extreme volatility. Comparison with FBRX, which focuses on skin treatments, helps to assess it as a high-risk asset.
Daily change in the price of a broad market stock, index - GURU.Markets
Forte Biosciences is a biotech company focused on treating skin diseases. Its shares are buoyed by anticipation of clinical trial results. These sharp, event-driven movements are part of a complex mosaic of stock market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Forte Biosciences Inc.
Forte Biosciences, Inc.'s year-to-date performance is a story of finding a new path after a clinical trial failure. Its trailing 12-month market cap reflects its status as a cash-rich company seeking a new asset for acquisition or merger. Its valuation is essentially the value of its cash and the belief that management will make the right move.
Annual dynamics of market capitalization of the market segment - Pharma skin
Forte Biosciences, Inc. is an early-stage biotech company focused on developing drugs for the treatment of skin diseases. Its stock performance is entirely dependent on the results of preclinical and clinical trials. The chart reflects the high risks and speculative nature of this sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Forte Biosciences is a clinical-stage biotech whose fate depends on scientific breakthroughs, not the state of the economy. Its stock price reflects investor hopes for the success of new drug trials. The company's chart exists in a world of its own, where the main events are data releases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Forte Biosciences Inc.
Forte Biosciences operates in the biotech sector, where news is king. Its monthly stock price performance is almost always a direct result of clinical trial results. A key trial failure can send the stock plummeting in a single day, while any hint of success can trigger a sharp rally, making the chart a reflection of the sector's binary risks.
Monthly dynamics of market capitalization of the market segment - Pharma skin
This chart reflects the dynamics of the volatile biotech sector. For Forte, a clinical-stage company, it's the backdrop. Its movements demonstrate how successes and, especially, failures in clinical trials can dramatically impact the valuation of such companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Forte Biosciences is a biopharmaceutical company focused on treating inflammatory skin diseases. Its future depends on the success of clinical trials. While the overall market chart provides only background, Forte's performance is driven by development news, which is typical in the biotech sector, where one result can change everything.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company focused on dermatology. Its weekly stock price, like many early-stage biotechs, will be highly volatile and dependent on news about clinical trials and regulatory decisions.
Weekly dynamics of market capitalization of the market segment - Pharma skin
Forte Biosciences is a dermatology company. After failing in key trials, its future is uncertain. The stock price of such companies is a story of binary risk in biotech, where the outcome of a single trial can be decisive. Compare its trajectory to the sector to see the implications of this risk.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Forte is a biotech company. Following a research setback, its shares are under pressure. The chart below shows how internal problems and scientific failures can cause the company's shares to move against the market and the sector as a whole, demonstrating binary risk.
Market capitalization of the company, segment and market as a whole
FBRX - Market capitalization of the company Forte Biosciences Inc.
Forte Biosciences' market capitalization chart following the failure of its key drug is a story of a search for a new target. Its low valuation reflects the company's status as a cash shell. Investors value it not by its existing pipeline, but by the likelihood of finding and acquiring a new, promising asset.
FBRX - Share of the company's market capitalization Forte Biosciences Inc. within the market segment - Pharma skin
Forte Biosciences is a clinical-stage biotech company focused on treating inflammatory skin diseases. Its market share reflects the potential of its developments. Its market capitalization represents a risky bet on success in the highly competitive field of dermatology.
Market capitalization of the market segment - Pharma skin
Here's a chart showing the biotech sector's market capitalization. Forte Biosciences is a company whose history, compared to the market, serves as a cautionary tale about risk. After failing a key clinical trial, the company is exploring new avenues for growth. Its performance is a striking illustration of how a single result can radically change the fate of biotech.
Market capitalization of all companies included in a broad market index - GURU.Markets
Forte Biosciences is a biopharmaceutical company developing drugs for the treatment of inflammatory skin diseases. Its market capitalization reflects the potential of its research in dermatology. The chart below shows the economic weight of companies in this field.
Book value capitalization of the company, segment and market as a whole
FBRX - Book value capitalization of the company Forte Biosciences Inc.
Forte Biosciences' book value is the capital remaining after its failed clinical trials. The chart tells the story of a biotech company seeking new assets or strategic alternatives. Its book value is essentially its liquidation value or the resource for a new start.
FBRX - Share of the company's book capitalization Forte Biosciences Inc. within the market segment - Pharma skin
Forte Biosciences is a biotech company focused on dermatology. The chart shows its share of actual R&D assets. These are its laboratories where research is conducted to develop new treatments for inflammatory skin diseases.
Market segment balance sheet capitalization - Pharma skin
Forte Biosciences is a biotech company whose value is locked into its development portfolio. Its business is capital-light. The chart below reflects the capital intensity of the pharmaceutical sector, which highlights its R&D-focused model.
Book value of all companies included in the broad market index - GURU.Markets
Forte Biosciences is a biopharmaceutical company focused on dermatology. Its assets include its R&D operations. A modest stake in BCap_All is a financial resource aimed at discovering new solutions for treating skin diseases such as atopic dermatitis.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company. Its market capitalization is lower than its book value (primarily cash). This reflects the failure of its key clinical trial and investor skepticism about its future.
Market to book capitalization ratio in a market segment - Pharma skin
Forte Biosciences is a biotech company focused on skin diseases. Its value is based almost entirely on its scientific potential. The chart shows the premium to book value that investors are paying for the company's hopes of developing breakthrough drugs in dermatology.
Market to book capitalization ratio for the market as a whole
Forte Biosciences is a biotech company focused on treating inflammatory skin diseases. Its valuation depends almost entirely on the success of clinical trials. This chart demonstrates how market value in the biotech sector can be detached from book value, reflecting hopes for future drugs.
Debts of the company, segment and market as a whole
FBRX - Company debts Forte Biosciences Inc.
Forte Biosciences, a biopharmaceutical company specializing in dermatological diseases, uses capital to fund its clinical research. Following failures in previous programs, its current debt policy is likely very conservative and aimed at supporting its remaining R&D projects at minimal cost.
Market segment debts - Pharma skin
Forte Biosciences is a biotech company focused on dermatological diseases. Currently in clinical trials, its success depends on trial results and funding. This chart shows the company's financial model for this risky path to developing new skin treatments.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company specializing in the treatment of inflammatory skin diseases. Its future depends on the success of clinical trials. This chart shows the extent to which the company finances its expensive R&D with debt. This is a key indicator of its financial risk in the path to potential drug approval.
Market segment debt to market segment book capitalization - Pharma skin
Forte Biosciences is a biopharmaceutical company focused on treating inflammatory skin diseases. The chart shows debt trends in their sector. For a company in the clinical trials stage, this allows them to assess how they finance their research and how their financial model, dependent on the success of these trials, compares to other dermatology startups.
Debt to book value of all companies in the market
Forte Biosciences is a biopharmaceutical company specializing in the treatment of inflammatory skin diseases. Currently in clinical trials, the company has no commercial revenue and relies on investor capital. This chart of the market's total debt clearly highlights Forte's financial model as a venture capital bet. Its success depends on trial results, not its ability to manage debt.
P/E of the company, segment and market as a whole
P/E - Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company focused on dermatology. This chart reflects the complex journey of biotech companies. Its dynamics demonstrate how clinical trial results can dramatically impact investor valuations, turning high hopes into disappointment, or vice versa.
P/E of the market segment - Pharma skin
This chart shows the average valuation for biotech companies, providing context for Forte Biosciences. It reflects overall speculative valuations in the sector. Comparisons with these valuations help understand how the market values the company following clinical failures and whether it believes in its ability to develop new drugs or find a new strategy.
P/E of the market as a whole
Forte Biosciences is a clinical-stage dermatology company. Its future was thrown into doubt after the failure of a key study. This chart of overall biotech risk appetite shows whether investors are willing to give companies a second chance after major clinical failures and whether they believe in their ability to find a new path.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Forte Biosciences Inc.
Forte Biosciences is a clinical-stage biopharmaceutical company specializing in the development of drugs for the treatment of inflammatory skin diseases. This chart reflects speculative investor expectations. The valuation depends almost entirely on the clinical trial results of its lead drug candidate and its potential in the dermatology market.
%20P%2FE%20Forte%20Biosciences%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Forte-Biosciences-Inc.&v=1772513917878 "Chart of the company's future (projected) P/E Forte Biosciences Inc.")
Future (projected) P/E of the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. This chart reflects investor expectations for the company's profitability relative to the sector. It allows one to assess how the market views its scientific developments and potential for developing new dermatological drugs.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-skin&v=1772513917967 "Future (projected) P/E graph of the market segment - Pharma skin")
Future (projected) P/E of the market as a whole
Forte Biosciences is a biopharmaceutical company focused on developing drugs for the treatment of inflammatory skin diseases. For a clinical-stage company like Forte, this market sentiment chart is important. A bullish market and investor willingness to fund innovation facilitate raising funds for expensive trials and research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513918057 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Forte Biosciences Inc.
Forte Biosciences is a pharmaceutical company developing drugs to treat inflammatory skin diseases. This chart reflects the company's financial expenditures and progress in clinical trials.
Profit of companies in the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company developing treatments for inflammatory skin diseases. This chart shows profitability in the pharmaceutical sector. For FBRX, this reflects the need for new treatments for conditions like atopic dermatitis. Their scientific approach is focused on understanding the skin microbiome.
Overall market profit
Forte Biosciences is a biotechnology company focused on developing treatments for inflammatory skin diseases. Following the failure of a key study, the company is exploring new strategic paths. Its future is uncertain and depends on new developments or acquisitions. This total profitability chart is not relevant to such specific corporate situations.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Forte Biosciences Inc.
Forte Biosciences is a clinical-stage biotechnology company focused on the treatment of inflammatory skin diseases. The revenue forecast presented here is speculative and reflects expectations of the success of its developments in clinical trials. Trial data is the only significant driver.
%20profit%20of%20the%20company%20Forte%20Biosciences%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Forte-Biosciences-Inc.&v=1772513918242 "Graph of future (projected) profit of the company Forte Biosciences Inc.")
Future (predicted) profit of companies in the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company specializing in dermatology. Its revenue outlook for this sector depends on the success of its clinical programs for the treatment of inflammatory skin diseases. This chart reflects analyst expectations for the future market for drugs for conditions such as atopic dermatitis.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-skin&v=1772513918257 "Graph of future (predicted) profits of companies in a market segment - Pharma skin")
Future (predicted) profit of the market as a whole
Forte Biosciences is a biopharmaceutical company specializing in the treatment of inflammatory skin diseases. Its value is determined by progress in clinical trials. Market-wide profit forecasts, reflected here, shape the investment climate, which affects the company's ability to attract R&D funding.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513918301 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Forte Biosciences Inc.
Forte Biosciences is a biotechnology company focused on developing drugs for the treatment of inflammatory skin diseases. This chart represents a speculative valuation. Following clinical trial failures, the company is exploring new avenues, and the current valuation reflects the uncertainty and risks associated with its future.
P/S market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company specializing in developing treatments for inflammatory skin diseases such as atopic dermatitis. This chart shows the average revenue estimate for the sector, which helps understand investor expectations for Forte's clinical trials and potential drugs.
P/S of the market as a whole
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. The company is in clinical trials, and its future value depends on their success. This chart provides a general market backdrop for assessing investor sentiment toward high-risk but potentially breakthrough medical technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. This chart shows how investors estimate the company's future revenue potential based on the success of its clinical trials.
%20P%2FS%20Forte%20Biosciences%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Forte-Biosciences-Inc.&v=1772513918491 "The graph of the company's future (projected) P/S Forte Biosciences Inc.")
Future (projected) P/S of the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company focused on developing drugs for the treatment of inflammatory skin diseases. This graph reflects investor expectations regarding the success of its clinical programs and the commercial potential of its dermatology developments.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20skin&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-skin&v=1772513918522 "Future (projected) P/S market segment graph - Pharma skin")
Future (projected) P/S of the market as a whole
Forte Biosciences is a clinical-stage biopharmaceutical company specializing in the treatment of inflammatory skin diseases. Their future depends entirely on the results of clinical trials. This market optimism chart is vital for FBRX. Funding for such risky projects is only possible when investors are optimistic and willing to wait for a scientific breakthrough.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513918535 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Forte Biosciences Inc.
Forte Biosciences is a clinical-stage biotechnology company specializing in the development of treatments for inflammatory skin diseases. Currently, the company has no commercial products. This timeline will show whether the company will be able to offer new, effective solutions for patients with dermatological problems.
Sales of companies in the market segment - Pharma skin
Forte Biosciences is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory skin diseases such as atopic dermatitis. Their lead candidate represents a novel therapeutic strategy. Being in the research stage, the company does not yet have commercial revenue from product sales.
Overall market sales
Forte Biosciences is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory skin diseases. Its research is aimed at creating new therapeutic approaches for patients with dermatological conditions. This total revenue chart includes the healthcare sector, where FBRX is pursuing solutions to improve skin health.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Forte Biosciences Inc.
Forte Biosciences is a dermatology company. After the failure of its key drug, it is exploring new avenues for development. This chart reflects analysts' speculative expectations regarding the company's ability to find a promising new asset or technology.
%20sales%20of%20the%20company%20Forte%20Biosciences%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Forte-Biosciences-Inc.&v=1772513918699 "Schedule of future (projected) sales of the company Forte Biosciences Inc.")
Future (projected) sales of companies in the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company developing drugs for the treatment of inflammatory skin diseases. This chart shows forecasts for the entire pharmaceutical dermatology market. It reflects the need for new treatments for common conditions, such as atopic dermatitis, and the potential for innovative approaches.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-skin&v=1772513918740 "Schedule of future (projected) sales of companies in the market segment - Pharma skin")
Future (projected) sales of the market as a whole
Forte Biosciences, a pharmaceutical company focused on dermatology, sees this chart as a reflection of consumer spending on health and beauty. Rising market revenue forecasts indicate an increase in disposable income. During such periods, people are more willing to spend on treatments for skin conditions such as atopic dermatitis.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513918814 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. Being in clinical trials, it incurs high R&D expenses. This chart does not represent current profits, but rather the company's investment in research to develop new therapeutic solutions.
Market segment marginality - Pharma skin
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. This chart reflects the potential of its research and development pipeline. Future strong operating income will confirm that its drugs can offer new solutions for patients.
Market marginality as a whole
Forte Biosciences is a clinical-stage biopharmaceutical company. Its value and future depend on the success of its scientific developments in dermatology. This total market return chart bears no relation to the world of clinical trials, scientific data, and regulatory decisions that determine Forte's fate.
Employees in the company, segment and market as a whole
Number of employees in the company Forte Biosciences Inc.
Forte Biosciences is a biopharmaceutical company focused on developing therapies for inflammatory skin diseases. This graphic shows a small team conducting clinical trials, aiming to develop new treatments for conditions like atopic dermatitis, which affect millions of people worldwide.
Share of the company's employees Forte Biosciences Inc. within the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company specializing in the treatment of inflammatory skin diseases. Developing new dermatological drugs requires a team of scientists and clinicians with a deep understanding of this field. This graph reflects its research intensity and talent pool focused on solving problems in dermatology.
Number of employees in the market segment - Pharma skin
Forte Biosciences is a pharmaceutical company focused on treating inflammatory skin diseases. This graphic shows a team of scientists working to discover new treatments for common conditions like atopic dermatitis, aiming to offer patients more effective and safer therapeutic solutions.
Number of employees in the market as a whole
Forte Biosciences, Inc. is a biopharmaceutical company focused on dermatology. Their success depends on scientific breakthroughs and the ability to fund clinical trials. The overall economic climate, as measured by employment trends, impacts the availability of capital. A growing economy stimulates investment in biotechnology, which is critical for companies in the development stage.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Forte Biosciences Inc. (FBRX)
Forte Biosciences, Inc. is a biopharmaceutical company focused on treating skin diseases. This chart reflects the risks and hopes of the biotech industry. The volatility of this indicator is enormous: a high market capitalization per employee before the announcement of trial results could collapse if the data proves negative.
%20of%20the%20company%20Forte%20Biosciences%20Inc.%20(FBRX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Forte-Biosciences-Inc.-FBRX&v=1772513919252 "Chart of market capitalization per employee (in thousands of dollars) of the company Forte Biosciences Inc. (FBRX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma skin
Forte Biosciences is a biopharmaceutical company focused on developing treatments for inflammatory skin diseases. Its value is determined by progress in clinical trials. This chart reflects investor expectations for its developments, showing its market valuation per employee compared to other biotech companies.
%20by%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-skin&v=1772513919276 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma skin")
Market capitalization per employee (in thousands of dollars) for the overall market
Forte Biosciences is a biopharmaceutical company focused on treating inflammatory skin diseases. For a clinical-stage biotech, this metric reflects investor expectations and demonstrates how the market perceives the potential of its leading product for addressing common dermatological concerns.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513919294 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Forte Biosciences Inc. (FBRX)
Forte Biosciences is a clinical-stage biotech company focused on dermatology. This graph is negative. After a failed trial, the company is looking for new avenues. Its staff (if it still has one) is spending its remaining capital on R&D, generating no profit.
%20Chart%20Forte%20Biosciences%20Inc.%20(FBRX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Forte-Biosciences-Inc.-FBRX&v=1772513919313 "Company Profit Per Employee (in thousands of dollars) Chart Forte Biosciences Inc. (FBRX)")
Profit per employee (in thousands of dollars) in the market segment - Pharma skin
Forte Biosciences (FBRX) is a clinical-stage biotech company specializing in developing treatments for inflammatory skin diseases such as atopic dermatitis. This chart represents an industry benchmark. For biotech R&D companies, it serves as a benchmark, demonstrating the potential profitability the sector aspires to achieve if their drug candidates are successful.
%20in%20the%20market%20segment%20-%20Pharma%20skin&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-skin&v=1772513919355 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma skin")
Profit per employee (in thousands of dollars) for the market as a whole
Forte Biosciences (FBRX) is a biotech company focused on developing drugs to treat inflammatory skin diseases such as atopic dermatitis. This is R&D. The chart shows the R&D investment (negative return) per scientist working on discovering new treatments for skin diseases.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513919357 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Forte Biosciences Inc. (FBRX)
Forte Biosciences is a biopharmaceutical company focused on the treatment of inflammatory skin diseases. This graph reflects the clinical development stage. Potentially high revenue per employee in the future will result from the successful launch of its drugs, which will translate scientific research into commercial products for a large patient population.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Forte-Biosciences-Inc.-FBRX&v=1772513919400 "Sales chart per company employee Forte Biosciences Inc. (FBRX)")
Sales per employee in the market segment - Pharma skin
Forte Biosciences (FBRX) is a clinical-stage biotech focused on dermatology. They have no commercial revenue. This chart reflects their R&D stage: their research staff is focused on research, resulting in zero revenue per employee compared to the industry average, which is dominated by blockbusters.
Sales per employee for the market as a whole
Forte Biosciences is a biotech company focused on developing drugs for the treatment of inflammatory skin diseases. It's a pure R&D operation. This graph will likely show zero revenue, as their research team is in the clinical trials phase.
Short shares by company, segment and market as a whole
Shares shorted by company Forte Biosciences Inc. (FBRX)
Forte Biosciences (FBRX) is a clinical-stage biotech focused on developing drugs for inflammatory skin diseases. This chart shows bearish bets. The high short interest reflects deep investor skepticism following the complete failure of their lead drug in clinical trials, casting doubt on the company's future.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Forte-Biosciences-Inc.-FBRX&v=1772513919483 "Short Shares Chart for the Company Forte Biosciences Inc. (FBRX)")
Shares shorted by market segment - Pharma skin
Forte (FBRX) is a biotech company specializing in dermatology, specifically the treatment of inflammatory skin diseases. This chart demonstrates the general skepticism in the biotech sector. It summarizes bearish bets, reflecting investor concerns about the risks of clinical trials in this complex niche.
Shares shorted by the overall market
Forte Biosciences (FBRX) is a clinical-stage biotech. Its value reflects the hope for future success. When this indicator of overall pessimism rises, investors are less inclined to hope. They are dumping unprofitable companies en masse that require constant refinancing for R&D, and FBRX is caught in the middle of this sell-off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Forte Biosciences Inc. (FBRX)
Forte Biosciences is a clinical-stage biotech. Its shares are extremely sensitive to trial news. This chart can surge above 70 on positive R&D data. Oversold territory (<30) often reflects research setbacks, funding concerns, or general risk aversion in biotech.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Forte-Biosciences-Inc.-FBRX&v=1772513919536 "RSI 14 indicator chart for the company's stock Forte Biosciences Inc. (FBRX)")
RSI 14 Market Segment - Pharma skin
Forte (FBRX) is a biotech company focused on treating inflammatory skin diseases. The RSI_14_Seg for "Pharma skin" (biotech) shows the overall sentiment. The chart helps us understand: is FBRX's volatility a reaction to its clinical trials, or is the entire sector overheated (or oversold)?
RSI 14 for the overall market
Forte Biosciences (FBRX) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast FBRX (Forte Biosciences Inc.)
Forte Biosciences (FBRX) is a clinical-stage biotech focused on developing treatments for inflammatory skin diseases. This chart shows the average target price. It reflects analysts' speculative valuations of the company's scientific platform and its early clinical trial data.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-FBRX-Forte-Biosciences-Inc.&v=1772513919579 "A chart showing analyst consensus forecasts for the expected stock price. FBRX (Forte Biosciences Inc.)")
The difference between the consensus estimate and the actual stock price FBRX (Forte Biosciences Inc.)
Forte Biosciences is a biotech company focused on developing drugs to treat inflammatory skin diseases such as atopic dermatitis. This chart shows the upside and downside potential analysts see for the stock. It measures the gap between the price and forecast, reflecting their confidence in their current R&D pipeline after past setbacks.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-FBRX-Forte-Biosciences-Inc.&v=1772513919624 "A chart showing the difference between the consensus forecast and the actual stock price. FBRX (Forte Biosciences Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma skin
Forte Biosciences is a biotech company focused on developing drugs for the treatment of inflammatory skin diseases (dermatitis). This chart shows analysts' overall expectations for the skin pharmaceutical sector. It reflects whether experts have confidence in the company's R&D pipeline after past trial failures.
Analysts' consensus forecast for the overall market share price
Forte Biosciences (FBRX) is a clinical-stage biotech focused on dermatology (skin treatments). This is a high-risk R&D company. This chart shows overall market sentiment. For Forte, as with any biotech, it's important to understand how the overall risk appetite (sentiment) impacts their ability to fund trials. (348)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Forte Biosciences Inc.
Forte Biosciences is a clinical-stage biotech company focused on developing drugs for the treatment of inflammatory skin diseases such as atopic dermatitis. This chart is a pure indicator of faith in their science. It doesn't reflect revenue, but rather a speculative estimate of their R&D progress and clinical trial data.
AKIMA Market Segment Index - Pharma skin
Forte Biosciences is a clinical-stage company specializing in developing treatments for inflammatory skin diseases such as atopic dermatitis. This chart shows the average index for the dermatology pharmaceutical sector. It provides a benchmark for how Forte's performance compares to the sector average for companies exploring new therapeutic options.
The AKIM Index for the overall market
Forte Biosciences is a biotech company developing immunomodulatory drugs for the treatment of autoimmune skin diseases. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this early-stage scientific play compares to overall economic trends and risk appetite.
